Synthesis of 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): A potential imaging agent of viral infection and gene therapy using PET

Nuclear Medicine and Biology

Volumn 23, Issue 6, 1996, Pages 787-792

  Alauddin, Mian M ^a   Conti, Peter S ^a   Mazza, Samuel M ^b,d   Hamzeh, Fayez M ^c   Lever, John R ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

DHPG; ganciclovir; gene therapy; viral infection

Indexed keywords

FLUORINE 18; GANCICLOVIR; 9 ((3 FLUORO 1 HYDROXY 2 PROPOXY)METHYL)GUANINE; 9-((3-FLUORO-1-HYDROXY-2-PROPOXY)METHYL)GUANINE; ANTIVIRUS AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE;

ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; GENE THERAPY; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; VIRUS INFECTION; CHEMISTRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; RADIOCHEMISTRY; SYNTHESIS;

ANTIVIRAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORINE RADIOISOTOPES; GANCICLOVIR; GENE THERAPY; ISOTOPE LABELING; RADIOCHEMISTRY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030204116     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(96)00075-3     Document Type: Article

References (32)

1. 18F for in vivo imaging by positron emission tomography. 206th American Chemical Society National Meeting. Chicago, IL, August 22-26.
2. 2. Becker E. D. (1980) High Resolution NMR, p. 99. Academic Press, New York.
3. 3. Cavalli L. (1976) Fluorine-19 NMR spectroscopy. In: Annual Report of NMR Spectroscopy (Edited by Mooney E. F.), Vol. 6B, pp. 43-100. Academic Press, New York.
4. 4. Cheng Y-C., Grill S. P., Dutschman G. E., Nakayama K. and Bastow K. F. (1983) Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound in herpes simplex virus-infected cells. J. Biol. Chem. 258, 12460-12464.
5. 11C]-FMAU): A potential nucleoside analogue for in vivo study of cellular proliferation with PET. Nucl. Med. Biol. 22, 783-789.
6. 11C]-Citalopram. Int. J. Radiat. Appl. Instrm. Part A 41, 541-543.
7. 7. De Clercq E. (1993) HIV inhibitors targeted at the reverse transcriptase. AIDS Res, Human Retrovir. 8, 119-133.
8. 8. Elion G. B., Furman P. A., Fyfe J. A., DeMiranda P., Bauchamp L. and Shaeffer H. (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc. Natl. Acad. Sci. USA. 74, 5716-5720.
9. 9. Germershausen J., Bostedor R., Field A. K., et al. (1983) A comparison of the antiviral agent 2′-nor-2′-deoxyguanosine and acyclovir: Uptake and phosphorylation in tissue culture and kinetics of in vitro inhibition of viral and cellular DNA polymerase by their respective triphosphates. Biochem. Biophys. Res. Comm. 116, 360-367.
10. 10. Groshar D., McEwan A. J. B., Parliament M. B., Urtasun R. C., Goldberg L. E., Hoskinson M., Mercer J., Mannan R. H., Wiebe L. I. and Chapman J. D. (1993) Imaging tumor hypoxia and tumor perfusion. J. Nucl. Med. 34, 885-888.
11. 11. Grunbaum Z., Freauff S. J., Krohn K. A., Wilbur D. S., Magee S. and Rasey J. S. (1987) Synthesis and characterization of congeners of misonidazole for imaging hypoxia. J. Nucl. Med. 28, 68-75.
12. 12. Kalley J. L. and Beauchamp L. (1983) Antiviral agents. Ann. Rep. Med. Chem. 18, 139-148.
13. 13. Kim U. C., Misco P. F., Luh B. Y., Hitchcock M. J. M., Ghazzouli I. and Martin J. C. (1991) A new class of acyclovir phosphonate nucleotide analogues: Phosphonate isosteres of acyclovir and ganciclovir mono-phosphates as antiviral agents. J. Med. Chem. 34, 2286-2294.
14. 14. Koh W. J., Rasey J. S., Evans M. L., Grierson, J. R., Lewellen T. K., Graham M. M., Krohn K. A. and Griffin T. W. (1992) Imaging of hypoxia in human tumors with [F-18]-fluoromisonidazole. Int. J. Radiat. Oncol. Biol. Phys. 22, 199-212.
15. 15. Martin J. C., Dvorak C. A., Smee D. F., Mathews T. R. and Verheyden J. P. H. (1983) 9-[(1,3-Dihydroxy-2-propoxy)-methyl]-guanine: A new selective antiherpes agent. J. Med. Chem. 26, 759-761.
16. 16. Martin J. C., McGee D., Jeffrey G., Hobbs D. W., Smee D. F., Mathews T. R. and Verheyden J. P. H. (1986) Synthesis and anti-herpes-virus activity of acyclic 2′-deoxyguanosine analogues related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine. J. Med. Chem. 29, 1384-1389.
17. 82Br]-labeled-5-halo-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)uracils. Appl. Radiat. Isot. 37, 901-905.
18. 18F-fluoro-3-hydroxy-2-propoxy)-methyl]guanine. 11th International Symposium on Radiopharmaceutical Chemistry. Vancouver, BC, Canada, pp. 193-195.
19. 19. Moore R. B., Chapman J. D., Mercer J. R., Mannan R. H., Wiebe L. I., McEwan A. J. and McPhee M. S. (1993) Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside. J. Nucl. Med. 34, 405-413.
20. 20. Ogilvie K. K., Hamilton R. G., Gillen M. F., Radatus B. K., Smith K. O. and Galloway K. S. (1984a) Uracil analogues of the acyclonucleoside 9-[2-hydroxy-1-hydroxymethyl)ethoxy]-methyl guanine (BIOLF-62). Can. J. Chem. 62, 16-21.
21. 21. Ogilvie K. K., Nghe Nguyen-Ba, Gillen M. F., Radatus B. K., Cheriyan U. O. and Hanna H. R. (1984b) Synthesis of a purine acyclonucleoside series having pronounced antiviral activity: The glyceropurines. Can. J. Chem. 62, 241-252.
22. 22. Oldfield E. H., Ram Zvi, Culver K. W., Blease R. M., DeVroom H. L. and Anderson W. F. (1993) Clinical protocols: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum. Gene Ther. 4, 39-69.
23. 23. Perlman M. F., Conti P. S., Schmall B. and Watanabe K. A. (1984) Synthesis and purification of the antiviral agent 1-(2-deoxy-2-fluoro-β-D-arahinofuranosyl)-5-iodocytosine (FIAC) labeled with iodine-125. Int. J. Nucl. Med. Biol. 11, 215-218.
24. 24. Ram Zvi, Culver K. W., Walbridge S., Walbridge S., Blease R. M. and Oldfield E. H. (1993) In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53, 83-88.
25. 25. Robins M. and Hatfield P. W. (1982) Nucleic acid related compounds: 37. Convenient and high yield synthesis of N-[(2-hydroxyethoxy)-methyl] heterocycles as acyclic nucleoside analogues. Can. J. Chem. 60, 547-553.
26. 26. Saito Y., Price R. W., Rottenburg D. A., Fox J. J., Su T. L., Watanabe K. A. and Philips F. S. (1982) Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug. Science 217, 1151-1153.
27. 27. Schaeffer H. J., Bauchamp L., De Miranda P., Elion G. B., Bauer D. J. and Collins P. (1978) 9-(2-Hydroxyethoxy)methyl-guanine activity against viruses of the herpes group. Nature 272, 583-585.
28. 28. Shelton E., Dence C. S., Hwang D. R., Welch M. J. and Bergmann S. R. (1989) Myocardial kinetics of fluorine-18-misonidazole: A marker of hypoxic myocardium. J. Nucl. Med. 30, 351-358.
29. 29. Since D. F., Martin J. C., Verheyden J. P. H. and Mathews T. R. (1983) Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Antimicrob. Agents Chemother. 23, 676-682.
30. 30. Srivastava P. C., Hasan A. and Buchsbaum D. J. (1991) Iodoazomycine acyclonucleosides: A potential SPECT imaging agent with high tumor uptake. J. Labelled Compds. Radiopharm. 30, 428-429.
31. 31. Tjuvajev J. G., Stockhammar G., Desai R., Uehera H., Watanabe K., Gansbacher B. and Blasberg R. G. (1995) Imaging the expression of transfected genes in vivo. Cancer Res. 55, 6126-6132.
32. 11C]N.-methyl acyclovir. J. Labelled Compds. Radiopharm. 29, 765-766.